首页 | 本学科首页   官方微博 | 高级检索  
     

Research on Autoantibodies Against Myocardial β1-adrenergic and M2 Cholinergic Receptors in Patients With Chronic Keshan Disease
作者姓名:韩振华 牛小麟 任付先
作者单位:Cardiovascular Department of The Second Hospital Xi'an Jiaotong University School of Medicine,Cardiovascular Department of The Second Hospital Xi'an Jiaotong University School of Medicine,Cardiovascular Department of The Second Hospital Xi'an Jiaotong University School of Medicine Xi'an 710004,China,Xi'an 710004,China,Xi'an 710004,China
摘    要:Objectives To explore the relationship between serum autoantibodies against myocardialβ1-adrenergic, M2-cholinergic receptors and chronic Keshan disease (CKD). Methods The second extracellular loops ofβ1 and M2 receptors on human cardiomyocytes were used as the antigens. Enzyme linked immunosorbent assay (ELISA) was applied to determine serum autoantibodies against myocardialβ1 and M2 receptors in 32 CKD patients. 31 healthy subjects from endemic area were selected as the control. Results Positive rate of autoantibodies against myocardialβ1 adrenergic (51.3%, 17/32) and M2 cholinergic (56.3% , 18/32) receptors were significantly higher than those in the control (9.7%, 3/ 31; 12.9%, 4/31) (both P< 0.01). Both positive rate and liters of above autoantibodies in NYHAⅡ-ⅢCKD patients were significantly higher than those in NYHAⅣ, demonstrating an apparently positive correlation between serum antibodies against myocardialβ1 and M2 receptors (r=0.95). Conclusions Autoantibodies against myocardialβ1 and M2 receptors were found in sera of CKD patients; distribution of positive rate and liters of the auloanlibodies in CKD patients in various NYHA classes of cardiac function are significantly different.

关 键 词:Keshan diseaseβ1-adrenergic receptor M2 cholinergic receptor Autoantibody
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号